Who Owns Diflucan?
Diflucan is owned by Pfizer, a publicly traded American multinational pharmaceutical company. Diflucan is Pfizer's antifungal treatment. Pfizer is headquartered in New York, USA and trades on NYSE (PFE).
Parent Company
Pfizer
Founded
1990
Status
Publicly Traded
Headquarters
New York, New York, USA
Who Owns Diflucan?
- Parent Company: Pfizer
- Ownership Type: Wholly owned
- Company Type: Publicly Traded
- Stock Ticker: NYSE: PFE
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Diflucan | Pfizer | Wholly owned |
History of Diflucan
- Founded: 1990
- Founders: Pfizer (internal development)
Diflucan was developed by Pfizer through extensive research into azole antifungals for treating fungal infections. The drug was approved by the FDA in 1990 as a treatment for candidiasis and other fungal infections. Diflucan represented an important advancement in antifungal therapy, offering patients an effective oral antifungal medication. This founding vision demonstrated exceptional insight into the growing demand for effective antifungal treatments while establishing a distinctive approach that would define the antifungal medication category for generations.
The development of Diflucan involved years of research into fluconazole and azole antifungal mechanisms. Pfizer conducted extensive clinical trials demonstrating the drug's efficacy in treating fungal infections. This period of research demonstrated Pfizer's exceptional ability to develop innovative pharmaceutical solutions while maintaining consistent scientific standards and clinical excellence that would define the brand for decades. Diflucan quickly became one of the most prescribed antifungal medications globally, creating a competitive advantage in the antifungal market.
Following its initial approval, Diflucan became available in multiple formulations including tablets, capsules, and intravenous formulations. This strategic expansion demonstrated Diflucan's exceptional ability to diversify its product offerings while maintaining its core brand identity and market leadership in the antifungal segment. The drug's effectiveness in treating fungal infections made it a standard treatment option for various fungal conditions. Diflucan became one of Pfizer's most successful antifungal products, demonstrating exceptional commercial success and clinical impact.
In recent decades, Diflucan has continued to maintain its position as a leading antifungal treatment. This continued evolution demonstrates Diflucan's exceptional ability to adapt to changing medical needs and scientific advancements while maintaining its core brand values and commitment to quality antifungal solutions. The drug has been approved in numerous countries worldwide and has become a standard therapy for fungal infections. Diflucan remains one of the leading azole antifungals in the market. This continued success represents a significant milestone in the evolution of antifungal medications and consumer-focused pharmaceutical solutions.
About Pfizer
What does Pfizer own?
Pfizer owns a portfolio of prescription medicines and vaccines spanning oncology, cardiovascular, immunology, vaccines, and rare diseases. Key products include Eliquis (blood thinner), Prevnar (pneumococcal vaccine), Ibrance (breast cancer), Vyndaqel (rare heart disease), Paxlovid (COVID-19 antiviral), and Comirnaty (COVID-19 vaccine, with BioNTech). The 2023 acquisition of Seagen added oncology antibody-drug conjugates including Padcev, Adcetris, and Tukysa.
Is Pfizer publicly traded?
Yes, Pfizer Inc. is listed on the New York Stock Exchange under ticker PFE. The company has been publicly traded since 1944. Pfizer has no single controlling shareholder, with major institutional holders including Vanguard Group, BlackRock, and State Street. Pfizer is a component of the Dow Jones Industrial Average and the S&P 500.
Who founded Pfizer?
Pfizer was founded in 1849 in Brooklyn, New York by Charles Pfizer and his cousin Charles Erhart. Charles Pfizer was a German-born chemist who emigrated to the United States. The company's first product was santonin, an antiparasitic agent. Pfizer's breakthrough into modern pharmaceuticals came during World War II when the company developed large-scale penicillin production.
Where is Pfizer headquartered?
Pfizer is headquartered in New York City, New York, USA. The company maintains its principal executive offices in Midtown Manhattan. Pfizer operates manufacturing facilities in the United States, Belgium, Ireland, the United Kingdom, Germany, Japan, China, India, and Brazil, and sells products in more than 125 countries worldwide.
How many products does Pfizer sell?
Pfizer sells dozens of prescription medicines and vaccines across multiple therapeutic areas. The company's portfolio includes products in oncology, vaccines, cardiovascular, immunology, rare diseases, and hospital products. More than a dozen of Pfizer's products each generate over $1 billion in annual revenue. The company's research pipeline includes hundreds of compounds in various stages of clinical development.
Who owns Pfizer?
Pfizer Inc. is publicly traded on the NYSE with a broad institutional and retail shareholder base. No single shareholder holds a controlling stake. Major institutional shareholders include Vanguard Group, BlackRock, and State Street. Albert Bourla serves as Chairman and CEO. Pfizer has no founding family or private equity controlling shareholder.
- Founded: 1849
- Headquarters: New York, New York, USA
- Company Type: Publicly Traded
- Stock: NYSE: PFE
Where Is Diflucan Made / Based?
- Headquarters: New York, New York, USA
- Manufacturing / Operations: United States, Belgium, Ireland, United Kingdom
Brands Owned by Pfizer
- Celebrex - Prescription anti-inflammatory medication for treating arthritis pain and inflam...
- Eliquis - Prescription anticoagulant medication for preventing blood clots and stroke in p...
- Leucovorin - Generic prescription folinic acid (5-formyltetrahydrofolate) used for methotrexa...
- Norvasc - Prescription calcium channel blocker medication for treating high blood pressure...
Diflucan Ownership: Pros & Cons
Advantages
- +Effective azole antifungal for fungal infections
- +Proven efficacy in treating candidiasis and other fungal infections
- +Available in multiple formulations for different patient needs
- +Backed by extensive clinical research and safety data
- +Supported by Pfizer's research capabilities and pharmaceutical expertise
- +Available globally with established distribution networks
- +Improved fungal infection treatment outcomes for patients
Considerations
- -Potential side effects including gastrointestinal effects
- -Requires complete course of treatment for effectiveness
- -Not suitable for patients with certain liver conditions
- -Requires prescription from healthcare provider
- -Competition from other antifungal medications
- -Potential for drug interactions with other medications
- -May require monitoring of liver function
Frequently Asked Questions About Diflucan
Where to Buy
Disclosure: We may earn commission from purchases
Diflucan on AmazonCompetitors to Diflucan
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Novartis | Switzerland | 2015 | Mass Market | Global | All Genders | |
| Kenvue | USA | 1974 | Mass Market | North America | All Genders | |
| Haleon | United Kingdom | 1976 | Mass Market | Global | All Genders | |
| Novartis | Switzerland | 2009 | Mass Market | Global | All Genders | |
| Takeda | Japan | 2018 | Mass Market | Asia Pacific | All Genders | |
| Merck | USA | 2008 | Mass Market | North America | All Genders |
Learn More About Competitors
Cosentyx
Owned by Novartis
Prescription biologic medication for treating autoimmune diseases including psoriasis, psoriatic arthritis, ankylosing spondylitis, hidradenitis suppurativa, and other inflammatory conditions.
Motrin
Owned by Kenvue
American brand of ibuprofen pain relief medication owned by Kenvue, the consumer health spinoff from Johnson & Johnson, which is being acquired by Kimberly-Clark in a $40 billion deal announced in November 2025.
Voltaren
Owned by Haleon plc
Over-the-counter anti-inflammatory pain relief brand containing diclofenac, owned by Haleon plc (LSE/NYSE: HLN) since its July 2022 spinoff from the GSK and Pfizer consumer health joint venture, with Voltaren growing mid-single digit in full-year 2025 supported by new format patches and Voltadexibu launches.
Afinitor
Owned by Novartis
Prescription oncology medication for treating various cancers including renal cell carcinoma and breast cancer, manufactured and marketed by Novartis.
Alofisel
Owned by Takeda Pharmaceutical Company
Prescription cell therapy for treating complex perianal fistulas in Crohn's disease, manufactured and marketed by Takeda Pharmaceutical Company.
Bridion
Owned by Merck & Co.
Prescription medication for reversing neuromuscular blockade during anesthesia, manufactured and marketed by Merck & Co.
Competitive Analysis
Market Positioning: Diflucan competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Pfizer Stock Information
Jobs at Pfizer
Latest News About Diflucan
Related Articles About Diflucan
View more articles
Pharmaceutical Brand Ownership: A Complete Guide
Who makes your medications? Discover which corporations own the biggest pharmaceutical brands, from Ozempic to Tylenol, and how pharma M&A affects you.
Brand Spin-offs: When Companies Sell Off Their Own Brands
From Kenvue to Kellanova, major corporations are spinning off iconic brands into independent companies. Learn why, how it works, and what it means for consumers.
Monthly M&A Roundup: February 2026 Brand Ownership Changes
From Keurig Dr Pepper's planned split to the Netflix-WBD saga, here is every major brand ownership change and deal in February 2026.
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Activase
Prescription thrombolytic medication for treating acute myocardial infarction and stroke, manufactured and marketed by Roche.
Acuvue
American brand of contact lenses and vision care products specializing in daily disposable and extended wear contact lenses, manufactured and marketed by Johnson & Johnson.
Adcetris
Prescription antibody-drug conjugate for treating Hodgkin lymphoma and other CD30-positive lymphomas, manufactured and marketed by Takeda Pharmaceutical Company.